Диссертация (1174314), страница 30
Текст из файла (страница 30)
Torng P.-L. Clinical implication for endometriosis associated with ovariancancer // Gynecology and Minimally Invasive Therapy. – 2017. – №6. – P.152-156.266. Trukhacheva E., Lin Z., Reierstad S. et al. Estogen receptor (ER) betaregulates ERalpha expression in stromal cells derived from ovarian endometriosis // JClin Endocrinol Metab. – 2009.
– Vol.94. – №.2. – P.615622 .267. Tsoumpou I., Kytgiou M., Gelbaya T.A. et al. The effect of surgery forendometriomas on ovarian response to gonatropin stimulation and pregnancy outcome:a systematic review and meta-analysis // Hum Reprod. – 2008. – Vol.23. – №.1. –P.8384.268. Ubaldi F., Wisanto A., Camus M. et al. The role of transvaginalultrasonography in the detection of pelvic pathologies in the infertility workup // HumReprod. – 1998. – Vol.13. – №2. – P.330-333.269.
Ulucus M., Arici A. Immunology of endometriosis // Minerva Ginecol. –2005. – №57. – P.237-248.175270. Umezawa M., Sakata C., Tanaka N. et al. Cytokine and chemokineexpression in a rat endometriosis is similar to that in human endometriosis // Cytokine.– 2008. – №.43. – P.105-109.271. Urman B., Alper E., Yakin K. et al. Removal of unilateral endometriomas isassociated with immediate and sustained reduction on ovarian reserve // Reprod BiomedOnline. – 2013. – Vol.16. – P.212-216.272. Van Gorp T., Veldman J., Van Calster B.
et al. Subjective assessment byultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarianmalignancy algorithm (ROMA) in discriminating benign from malignant adnexalmasses // Eur J Cancer. – 2012. – Vol.48. – №11. – P.1649-1656.273. Van Holsbeke C., Van Calster B., Guerriero S. et al. Endometriomas: theirultrasound characteristics // Ultrasound Obstet Gynecol. – 2010. – Vol.35. – №6. –P.730-740.274. Vercellini P., Consonni D., Somigliana E. et al. «Waiting for Godot»: acommonsense approach to the medical treatment of endometriosis // Hum Reprod.
–2011. – Vol.26. – P.313.275. Vercellini P., Somigliana E., Consonni D. et al. Surgical versus medicaltreatment for endometriosis-associated severe depp dyspareunia: I. Effect on pain duringintercourse and patient satisfaction // Hum Reprod. – 2012. – Vol.27. – №.12. –P.34503459.276. Vercellini P., Frontino G., De Giorgi O. et al. Continuous use of an oralcontraceptive for endometriosis-associated recurrent dysmenorrheal that does notrespond to a cyclic pill regimen // Fertil Steril.
– 2003. – Vol.80. – P.560-563.277. Vodolazkaia A., Yesilyurt B.T., Kyama C.M. Vascular endothelial growthfactor pathway in endometriosis: genetic variants and plasma biomarkers // Fertil Steril.– 2016. – Vol.105. – №4. – P.988-996.278. Wang D., Chen Q., Zhanq C. et al. DNA hypomethylation of the COX-2gene promoter is associated with up-regulation of its mRNA expression in eutopicendometrium of endometriosis // Eur J Med Res. – 2012.
– Vol.18. – №.17. – P.12-18.176279. Wang W.T., Zhao Y.N., Han B.W. et al. Circulating microRNAs indified in agenome-wide serum microRNA expression analysis as noninvasive biomarkers forendometriosis // J Clin Endocrinol Metab. – 2013. – Vol.98. – №1. – P.281-289.280. Wu Y., Starzinski-Powitz A., Guo S.W. Prolonged stimulation with tumornecrosis factor-α induced partial methylation at PR-B promoter in immortalizedepithelial-like endometriotic cells // Fertil Steril. – 2008.
– Vol.90. – P.234-237.281. Wu Y., Strawn E., Basir Z. et al. Aberrant expression of deoxyribonucleicacid methyltransferases DNMT1, DNMT3A, and DNMT3B in women withendometriosis // Fertil Steril. – 2007. – Vol.87. – P.24-32.282. Wu Y., Strawn E., Basir Z. et al. Promoter hypomethylation of progesteronereceptor isoform B (PR-B) in endometriosis // Epigenetics. – 2006.
– №.1. – P.106-111.283. Xavier P., Belo L., Beries L. et al. Serum levels of VEGF and TNF-α andtheir association with C-reactive proteins in patients with endometriosis // Arch GynecolObstet. – 2006. –№273. – P.227-231.284. Xiao W., Awadallah A., Xin W. Loss of ARID1A/BAF250a expression inovarian endometriosis and clear cell carcinoma // Int J Clin Exp Pathol. – 2012. – Vol.5.– №7. – P.642-650.285.
Xiao-xia W., Jia-li K., Xue-fei S. et al. Effect of GnRHa on apoptosis andrelease of VEGF in endometrial cell culture from patients with adenomyosis // Xi BaoYu Fen Zi Mian Yi Xue Za Xhi. – 2012. – Vol.28. – №.1. – P.72-73..286. Xing D., Feng W., Miller A.P. et al. Estogen modulates TNF-α-inducedinflammatory responses in rat aortic smooth muscle cells through estrogen receptor-βactivation // Am J Physiol Heart Circ Physiol. – 2007. – №292. – H2566-H2569.287. Xu H., Zhang T., Man G.C.
et al. Vascular endothelial growth factor C isincreased in endometrium and promotes endothelial functions, vascular permeabilityand angiogenesis and growth of endometriosis // Angiogenesis. – 2013. – Vol.16(3). –P.541-551.288. Xue Q., Lin Z., Cheng Y.H. et al. Promoter methylation regulates estrogenreceptor 2 in human endometrium and endometriosis // Biol Reprod.
– 2007. – №.77. –P.681-687.177289. Yalcin S.E., Ocal I., Yalcin Y. et al. Evaluation of the Ki-67 ProliferationIndex and Urocortin Expression in Women with Ovarian Endometriomas // Eurasian JMed. – 2017. – Vol.49. – №2. – P.107-112.290. Yamaguchi K., Mandai M., Oura T. et al. Idntification of an ovarian clearcell carcinoma gene signature that reflects inherent disease biology and the carcinogenicprocesses // Oncogene. – 2010. – №29.
– P.1741-1752.291. Yamaguchi K., Mandai M., Toyokuni S. et al. Contents of endometrioticcysts, especially the high concentration of free iron, are a possible cause ofcarcinogenesis in the cysts through the iron-induced persistent oxidative stress // ClinCancer Res.
– 2008. – №14. – P.32-40.292. Yang J.H., Wu M.Y., Chen C.D. et al. Altered apoptosis and proliferation inendometrial stromal cells of women with adenomyosis // Hum Reprod. – 2007. –Vol.22. – №4. – P.945-952.293. Zafran N., Levin A., Goldman S., Shalev E.
Progesterone receptor’s profileand the effect of the hormone and its derivatives on invasiveness and MMP2 secretionin endometrial carcinoma cell lines // Harefuah. – 2009. – Vol.148. – №7. – P.416-419.294. Zec I., Tislaric-Medenjak D., Megla Z.B. et al. Anti-Mullerian hormone: aunique biochemical marker of gonadal development and fertility in humans // BiochemMed (Zagreb). – 2011. – Vol.21.
– №3. – P.219-23.178.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
